Screening for prostate cancer

D Ilic, MM Neuberger, M Djulbegovic… - Cochrane database of …, 2013 - cochranelibrary.com
Background Any form of screening aims to reduce disease‐specific and overall mortality,
and to improve a person's future quality of life. Screening for prostate cancer has generated …

Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology

JP Droz, M Aapro, L Balducci, H Boyle… - The lancet …, 2014 - thelancet.com
Summary In 2010, the International Society of Geriatric Oncology (SIOG) developed
treatment guidelines for men with prostate cancer who are older than 70 years old. In 2013 …

Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis

M De Rooij, EHJ Hamoen, JJ Fütterer… - American Journal of …, 2014 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this diagnostic meta-analysis was to determine the diagnostic
accuracy of multiparametric MRI for prostate cancer detection using anatomic T2-weighted …

The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer

L Klotz, L Boccon‐Gibod, ND Shore… - BJU …, 2008 - Wiley Online Library
OBJECTIVE To evaluate the efficacy and safety of degarelix, a new gonadotrophin‐
releasing hormone (GnRH) antagonist (blocker), vs leuprolide for achieving and maintaining …

Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome …

A Aversa, R Bruzziches, D Francomano… - The journal of sexual …, 2010 - academic.oup.com
Introduction Longitudinal studies have demonstrated that male hypogonadism could be
considered a surrogate marker of incident cardiovascular disease. Aim To evaluate the …

Models of cancer survivorship care: overview and summary of current evidence

MT Halpern, M Viswanathan, TS Evans… - Journal of oncology …, 2015 - ascopubs.org
Introduction: This article, derived from a Technical Brief prepared for the Agency for
Healthcare Research and Quality, presents an overview on current models of care for …

Applications of transrectal ultrasound in prostate cancer

CJ Harvey, J Pilcher, J Richenberg… - The British journal of …, 2012 - academic.oup.com
Transrectal ultrasound (TRUS) was first developed in the 1970s. TRUS-guided biopsy,
under local anaesthetic and prophylactic antibiotics, is now the most widely accepted …

Is it time to consider a role for MRI before prostate biopsy?

HU Ahmed, A Kirkham, M Arya, R Illing… - Nature reviews Clinical …, 2009 - nature.com
The use of MRI in prostate cancer management is controversial and current guidelines
underplay its role. Technological advances over the past 5 years, however, demand a re …

Advances in magnetic resonance imaging: how they are changing the management of prostate cancer

A Sciarra, J Barentsz, A Bjartell, J Eastham, H Hricak… - European urology, 2011 - Elsevier
CONTEXT: Although magnetic resonance imaging (MRI) is emerging as the most commonly
used imaging modality for prostate cancer (PCa) detection, treatment planning, and follow …

Enzalutamide: targeting the androgen signalling pathway in metastatic castration‐resistant prostate cancer

J Schalken, JM Fitzpatrick - BJU international, 2016 - Wiley Online Library
Significant progress has been made in the understanding of the underlying cancer biology
of castration‐resistant prostate cancer (CRPC) with the androgen receptor (AR) signalling …